Compare PNNT & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNNT | MLAB |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.8M | 441.2M |
| IPO Year | 2007 | N/A |
| Metric | PNNT | MLAB |
|---|---|---|
| Price | $5.86 | $77.50 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $6.04 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 797.8K | 179.0K |
| Earning Date | 11-24-2025 | 11-06-2025 |
| Dividend Yield | ★ 16.44% | 0.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | $122,377,000.00 | ★ $245,255,000.00 |
| Revenue This Year | N/A | $4.96 |
| Revenue Next Year | N/A | $5.27 |
| P/E Ratio | $11.65 | ★ N/A |
| Revenue Growth | N/A | ★ 7.39 |
| 52 Week Low | $5.66 | $55.45 |
| 52 Week High | $7.53 | $155.12 |
| Indicator | PNNT | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.24 | 53.91 |
| Support Level | $5.66 | $70.19 |
| Resistance Level | $6.11 | $82.87 |
| Average True Range (ATR) | 0.17 | 3.86 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 22.37 | 60.82 |
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.